257 related articles for article (PubMed ID: 21606346)
1. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses.
Sarin R; Wu X; Abraham C
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9560-5. PubMed ID: 21606346
[TBL] [Abstract][Full Text] [Related]
2. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans.
Di Meglio P; Di Cesare A; Laggner U; Chu CC; Napolitano L; Villanova F; Tosi I; Capon F; Trembath RC; Peris K; Nestle FO
PLoS One; 2011 Feb; 6(2):e17160. PubMed ID: 21364948
[TBL] [Abstract][Full Text] [Related]
3. IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes.
Sun R; Hedl M; Abraham C
Gut; 2020 Feb; 69(2):264-273. PubMed ID: 31097538
[TBL] [Abstract][Full Text] [Related]
4. IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant.
Sun R; Abraham C
Cell Mol Gastroenterol Hepatol; 2020; 10(4):673-697. PubMed ID: 32474165
[TBL] [Abstract][Full Text] [Related]
5. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q.
Pidasheva S; Trifari S; Phillips A; Hackney JA; Ma Y; Smith A; Sohn SJ; Spits H; Little RD; Behrens TW; Honigberg L; Ghilardi N; Clark HF
PLoS One; 2011; 6(10):e25038. PubMed ID: 22022372
[TBL] [Abstract][Full Text] [Related]
6. Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.
Shen H; Zhang W; Abraham C; Cho JH
PLoS One; 2013; 8(3):e57746. PubMed ID: 23469228
[TBL] [Abstract][Full Text] [Related]
7. IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking.
Sivanesan D; Beauchamp C; Quinou C; Lee J; Lesage S; Chemtob S; Rioux JD; Michnick SW
J Biol Chem; 2016 Apr; 291(16):8673-85. PubMed ID: 26887945
[TBL] [Abstract][Full Text] [Related]
8. Human basophils interact with memory T cells to augment Th17 responses.
Wakahara K; Baba N; Van VQ; Bégin P; Rubio M; Ferraro P; Panzini B; Wassef R; Lahaie R; Caussignac Y; Tamaz R; Richard C; Soucy G; Delespesse G; Sarfati M
Blood; 2012 Dec; 120(24):4761-71. PubMed ID: 23071273
[TBL] [Abstract][Full Text] [Related]
9. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review.
Abdollahi E; Tavasolian F; Momtazi-Borojeni AA; Samadi M; Rafatpanah H
J Immunotoxicol; 2016 May; 13(3):286-300. PubMed ID: 27043356
[TBL] [Abstract][Full Text] [Related]
10. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
11. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.
Brunsing RL; Prossnitz ER
Immunology; 2011 Sep; 134(1):93-106. PubMed ID: 21722102
[TBL] [Abstract][Full Text] [Related]
12. The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients.
Di Meglio P; Villanova F; Napolitano L; Tosi I; Terranova Barberio M; Mak RK; Nutland S; Smith CH; Barker JNWN; Todd JA; Nestle FO
J Invest Dermatol; 2013 Oct; 133(10):2381-2389. PubMed ID: 23563201
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-23/Th17 pathways and inflammatory bowel disease.
Abraham C; Cho J
Inflamm Bowel Dis; 2009 Jul; 15(7):1090-100. PubMed ID: 19253307
[TBL] [Abstract][Full Text] [Related]
14. Boswellic acids reduce Th17 differentiation via blockade of IL-1β-mediated IRAK1 signaling.
Stürner KH; Verse N; Yousef S; Martin R; Sospedra M
Eur J Immunol; 2014 Apr; 44(4):1200-12. PubMed ID: 24469975
[TBL] [Abstract][Full Text] [Related]
15. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
16. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.
Butler MO; Imataki O; Yamashita Y; Tanaka M; Ansén S; Berezovskaya A; Metzler G; Milstein MI; Mooney MM; Murray AP; Mano H; Nadler LM; Hirano N
PLoS One; 2012; 7(1):e30229. PubMed ID: 22279573
[TBL] [Abstract][Full Text] [Related]
18. Modulation of CD4
Anuradha R; Munisankar S; Bhootra Y; Dolla C; Kumaran P; Nutman TB; Babu S
Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28874444
[No Abstract] [Full Text] [Related]
19. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
20. IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.
Schneider R; Yaneva T; Beauseigle D; El-Khoury L; Arbour N
Eur J Immunol; 2011 Jan; 41(1):47-59. PubMed ID: 21182076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
